Hints and tips:
...From the pharmaceuticals sector, Bristol-Myers Squibb — which recently agreed to buy Celgene in one of the largest pharmaceutical deals in history — reports....
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
...The sale allows Bristol-Myers Squibb to push ahead with its mammoth $90bn takeover of Celgene....
International Edition